An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary Glioblastoma



Watts, Colin, Ashkan, Keyoumars, Jenkinson, Michael D ORCID: 0000-0003-4587-2139, Price, Stephen J, Santarius, Thomas, Matys, Tomasz, Zhang, Ting Ting, Finch, Alina, Collins, Peter, Allinson, Kieren
et al (show 8 more authors) (2021) An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary Glioblastoma. CANCERS, 13 (13).

[img] Text
2021_GALA-5 trial.pdf - OA Published Version

Download (1MB) | Preview
Item Type: Article
Uncontrolled Keywords: glioblastoma, 5-aminolevulinic acid, BCNU wafers, chemoRT, feasibility trial
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User: Symplectic Admin
Date Deposited: 08 Jul 2021 08:21
Last Modified: 14 Sep 2022 11:41
DOI: 10.3390/cancers13133241
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3129129